Bryce Point Capital, LLC
- SEC CIK
- 0002019492
- Latest filing
- Nov 6, 2025
BBIO holding history
BridgeBio Pharma, Inc. in every 13F filed by Bryce Point Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BBIO overviewAll 13F holders of BBIOFull Q3 2025 holdings
- Shares (Q3 2025)
- 11,717
- Value
- $608.6K
- % of portfolio
- 0.7%
- Quarters held
- 2
- Since Q2 2025